RESEARCH INDEX

Peptide Research Knowledge Base

Browse structured answers, product research, comparisons, storage information, and frequently searched peptide topics.

ALL KNOWLEDGE ARTICLES

Page 191 of 483 · 9,653 published
04
KNOWLEDGE ARTICLE

SLU-PP-332 Half-Life: What Research Shows

SLU-PP-332 half-life is short in rodent studies—roughly one to two hours—but no human pharmacokinetic data exist. Learn what that means for dosing research.

↗
05
KNOWLEDGE ARTICLE

Semax Peptide Review: Effects, Results & Safety

This semax peptide review breaks down what users report about focus, dosing, nasal spray vs. injection, and safety. Plus what research does and doesn't show.

↗
06
KNOWLEDGE ARTICLE

Are Research Peptides Safe? Reddit Insights

Are research peptides safe? Reddit discussions reveal mixed opinions. Learn about purity, vendor risks, and legal status before considering research peptides.

↗
07
KNOWLEDGE ARTICLE

US Peptide Research: A Guide for Lab Buyers

US peptide research covers sourcing, purity testing, and legal status. Learn how labs vet suppliers of semaglutide, tirzepatide, and other research peptides.

↗
11
KNOWLEDGE ARTICLE

Does BPC-157 Make You Tired? Fatigue Explained

Does BPC-157 make you tired? Here's what current research and user reports suggest about fatigue, sleep, dosing, and safety with this peptide.

↗
18
KNOWLEDGE ARTICLE

Simple Peptides Reviews Complaints: What to Know

Simple peptides reviews complaints can be confusing. This balanced guide covers what US researchers report, red flags, pricing, and safety before you buy.

↗
19
KNOWLEDGE ARTICLE

CJC-1295/Ipamorelin Safety: Key Risks to Know

CJC-1295/Ipamorelin safety involves injection-site issues, hormone shifts, and unclear long-term effects. Here's what research shows and what to ask a doctor.

↗
20
KNOWLEDGE ARTICLE

CJC-1295 No DAC Ipamorelin 10mg Blend Dosage Guide

Learn about CJC-1295 no DAC ipamorelin 10mg blend dosage, typical protocols, and safety considerations. This research peptide is not FDA-approved for human use.

↗